Cardiac Primary Prevention Research Center, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
Atherosclerosis. 2017 Aug;263:343-351. doi: 10.1016/j.atherosclerosis.2017.06.001. Epub 2017 Jun 2.
Cardiovascular disease (CVD) and cancer are leading causes of mortality and morbidity worldwide. Strategies to improve their treatment and prevention are global priorities and major focus of World Health Organization's joint prevention programs. Emerging evidence suggests that modifiable risk factors including diet, sedentary lifestyle, obesity and tobacco use are central to the pathogenesis of both diseases and are reflected in common genetic, cellular, and signaling mechanisms. Understanding this important biological overlap is critical and may help identify novel therapeutic and preventative strategies for both disorders. In this review, we will discuss the shared genetic and molecular factors central to CVD and cancer and how the strategies commonly used for the prevention of atherosclerotic vascular disease can be applied to cancer prevention.
心血管疾病(CVD)和癌症是全球范围内导致死亡和发病的主要原因。改善其治疗和预防的策略是全球的重点,也是世界卫生组织联合预防计划的主要关注点。新出现的证据表明,包括饮食、久坐不动的生活方式、肥胖和吸烟在内的可改变的危险因素是这两种疾病发病机制的核心,并且反映在共同的遗传、细胞和信号转导机制中。了解这一重要的生物学重叠至关重要,并且可能有助于为这两种疾病确定新的治疗和预防策略。在这篇综述中,我们将讨论与 CVD 和癌症相关的核心遗传和分子因素,以及常用于预防动脉粥样硬化性血管疾病的策略如何应用于癌症预防。